李歆

发布时间:2020-07-01浏览次数:10521



李歆

博士,教授,博士生导师

 

电子邮箱:xinli@njmu.edu.cn

 

主要研究方向:临床药学、药事管理、药物经济与药物政策研究

 

博士招生专业方向:健康政策与管理、临床药学

 

硕士招生专业方向:临床药学、药学、公共管理

 

个人简介:

 

现任澳门威斯人0168副院长、医政学院互聘教授,公共卫生学院全球健康中心PI,校优秀中青年学科(学术)带头人。主要研究领域:药事管理、药物政策、临床药学、药物经济、科技管理等。兼任中国药品监管研究会药品监管史委员会委员、江苏省药学会药学服务专委会副主任委员、江苏省医疗保险研究会常务理事、江苏省药师协会常务理事、江苏省研究型医院学会精益化用药研究与转化专业委员会委员、南京市药学会药事管理专业委员会委员、南京医科大学学报(社会科学版)编委。中国药学、Pharmacological Research、Frontiers in PharmacologyBMJ Open等国内外期刊审稿人,国家自然科学基金委员会管理学部同行评议专家。先后主持3项国家自然科学基金项目,以第一或通讯作者在SSCI/SCI、北大核心期刊发表了50余篇医药卫生管理的学术论文主编2部学术专著,受邀参与“健康江苏2030规划纲要”的撰写。2012年奥地利维也纳经济与商业大学访问学者2014年-2015年美国东卡莱罗那大学访问学者。先后获校扬子江奖教金优秀奖、校三全育人标兵、校优秀共产党员等荣誉称号。已培养药学、临床药学、公共管理硕士研究生20多名,指导硕士研究生多次获得国家奖学金。

 

主要开设课程:药物经济学、药事管理与法规、医药营销、临床药学导论

 

代表性研究项目:

 

1 创新抗癌药物医保覆盖对癌症用药可及性与经济性的影响:价值视角下的政策评估与优化研究. 国家自然科学基金面上项目,2021年-2024年.项目批准号:72074123,负责人;(经费:48万)

2.基于AMS策略导向的医院抗菌药物管理模式构建:综合评价与准实验干预研究.国家自然科学基金面上项目,2017年-2020年.项目批准号:71673147,负责人;(经费:48万)

3. 医院临床药学服务的影响因素分析与质量评价研究. 国家自然科学基金青年项目,2011-2013年. 项目批准号:71003055,负责人;(经费:17万)

4.The impact of clinical pharmacy services on the quality use of medicines in context of China’s healthcare provider payment reform: a multicenter cluster-randomized controlled trial. 美国中华医学基金会公开竞争项目(CMB-OC),2018年-2020年。(经费:4万美元)

5.基于终端数据的江苏省医药产业竞争力研究,江苏省政策引导类(软科学)研究项目,2020年-2021年,项目批准号:BR2020043(经费:5万)

代表性研究成果:

药物经济学:

1. Xinglu Xu, Nan Fang, Huanan Li, Yanyan Liu, Fan Yang*, Xin Li*,Cost-effectiveness Analysis of Dacomitinib versus Gefitinib for the First-line Therapy of Patients with EGFR-mutation-positive Non-small Cell Lung Cancer in United States and China,Annals of Translational Medicine,2021 May;9(9):760.(SCI 收录)

2. Zhuolin Zhang, Lele Cai, Hong Wu, Xinglu Xu, Wenqing Fang, Xuan He, Xiao Wang,Xin Li* Paricalcitol versus Calcitriol+Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis, Frontiers in Public Health,2021,9:712027. (SSCI&SCI收);

3. Bin Wan, Nan Fang, Wei Guan, Haixia Ding, Ying Wang, Xin Ge, Hui Liang, Xin Li*, Yiyang Zhan*. Cost-Effectiveness of Bariatric Surgery versus Medication therapy for Obese Patients with Type 2 Diabetes in China: A Markov Analysis. Journal of Diabetes Research,2019 Dec 19;2019:1341963.(SCI收录);

药物政策与药事管理:

4. Wenqing Fang, Xinglu Xu, Yulei Zhu, Huizhen Dai, Linlin Shang*, Xin Li* Impact of the National Health Insurance Coverage Policy on the Utilisation and Accessibility of Innovative Anti-Cancer Medicines in China: An Interrupted Time-Series Study. Frontiers in Public Health,2021,9:714127  (SSCI&SCI收);

5. Zhu Y, Xu X, Fang W, Wang Y, Dai H, Li X*. Availability, cost and affordability of selected antibiotics and antiviral medicines against infectious diseases from 2013 to 2019 in Nanjing, China. Trop Med Int Health. 2021 May;26(5):518-529. (SCI 收录)

6. Ying Wang ,Yulei Zhu ,Hang Shi , Xiaoluan Sun ,Na Chen, Xin Li*.  The Effect of the Full Coverage of Essential Medicines Policy on Utilization and Accessibility of Primary Healthcare Service for Rural Seniors: A Time Series Study in Qidong, China. International journal of environmental research and public health, 2019, 16(22): 4316. (SSCI&SCI收录);

7. Yulei Zhu, Ying Wang, Xiaoluan Sun, Xin Li*. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China. International Journal of Environmental Research and Public Health, 2019, 16(19): 3728. (SSCI&SCI收录);

8. Xiaoluan Sun, Jing Wei, Yuan Yao, Qiutong Chen, Daiting You, Xinglu Xu, Jing Dai, Yanping Yao, Jingyi Sheng, Xin Li*. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China. BMJ open, 2018, 8(10): e023646.(SCI收录);

临床药学

9. 临床药学服务的质量评价与管理策略,专著,人民卫生出版社,26万字,2018年1月。

10. Yuan He, Fan Yang, Dongqin Mu, Yuan Xing, Xin Li*. Examination of psychosocial predictors of Chinese hospital pharmacists’ intention to provide clinical pharmacy services using the theory of planned behaviour: a cross-sectional questionnaire study,BMJ Open, 2016;6:e012775. (SCI 收录);

11. Hai-Xia Zhang, Xin Li*, Hai-Qin Huo, Pei Liang, Jin-Ping Zhang, Wei-Hong Ge*. Pharmacist Interventions for Prophylactic Antibiotic Use in Urological Inpatients Undergoing Clean or Clean-contaminated Operations in A Chinese Hospital, PLoS ONE, 2014,9(2): e88971. (SCI收录);

12. Xin Li*, Haiqin Huo, Wenjun Kong, Fan Li, Jingwen Wang. Physicians’perceptions and attitudes toward clinical pharmacy services in urban general hospitals in China, International Journal of Clinical Pharmacy, 2014,36:443–450. (SCI收录);

科技管理与政策

13. Sheng-qiang Jiang, Anna Shi*,Zhi-hang Peng, Xin Li*, Major factors affecting cross-city R&D collaborations in China: Evidence from cross-sectional co-patent data between 224 cities. Scientometrics, 2017 , 111(3): 1251-1266.  (SSCI&SCI收录,管理学II区);

教学改革研究

14. Yuan He, Jun Lu, Huaxing Huang, Shutong He, Nina Ma, Zimo Sha, Yanjun Sun, Xin Li*. The effects of flipped classrooms on undergraduate pharmaceutical marketing learning: A clustered  randomized controlled study. PloS ONE, 2019, 14(4): e0214624. (SCI收录);

 


Baidu
sogou